The company’s exhibitions will be focused in the areas of its pipeline, proprietary capsid engineering, and manufacturing.

Good day, and welcome to the Stoneridge first-quarter 2025 conference call. (Operator Instructions) Please note this event is being recorded. I would now like to attend the conference over to Kelly ...

BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics for the treatment of solid tumors, ...

SAN DIEGO, April 29, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell ...

Highlights from Prelude’s efforts to discover and develop selective KAT6A degraders, including preclinical data, demonstrating potential for a differentiated efficacy and safety profile ...

Six students from Jeff Tech described their shops and spoke of their accomplishments in a presentation to the Brookville Area ...

The Advanced Materials and Manufacturing Program (AMMP) through the nonprofit MTEC SmartZone in Houghton launched its ...

Q1 2025 Earnings Conference Call May 1, 2025 8:30 AM ETCompany ParticipantsJennifer Halchak - VP, IRKevin Ali - CEOMatt Walsh ...

Learn how to create professional diagrams, flowcharts, and organizational charts with this beginner-friendly Microsoft Visio ...

Mabwell (688062.SH), an innovation-driven biopharmaceutical company with an entire industry chain, announced that the Phase Ib/II clinical study results of the novel Nectin-4-targeting ADC 9MW2821 ...